openPR Logo
Press release

Anal Cancer Therapeutics Market to Witness a Pronounce Growth During 2016-2024

05-23-2018 11:48 AM CET | Health & Medicine

Press release from: Persistence Market Research pvt ltd

Anal Cancer Therapeutics Market to Witness a Pronounce Growth

A cancer can be defined when the normal cells lose their ability to control, their growth or multiplication and thus invade the tissues and spread to the body parts. Anal cancer is often called as squamous cell carcinoma which arises from the cells around or in the anal opening or in rare cases it may cause in the anal canal. This type of cancer is usually associated with human papiloma virus (HPV), where HPV cancers or cervical cancers have a high risk of developing into anal cancer. There are no exact symptoms for anal cancer as such but some might show bleeding from the anal area, lump or swelling near anus or change in the bowel habits etc. Staging is a way which describes the location of cancer, the stages include tumor, node and metastasis which is further grouped I, II, IIIA, IIIB and IV. The different types of anal cancer include melanoma, adenocarcinoma, basaloid transitional and cloacogenic cancer.

Request to Sample of Report @ https://www.persistencemarketresearch.com/samples/10658

The statistics for anal cancer suggest that annually there about 6000 cases of anal cancer diagnosed in the U.S. and the number is increasing slowly. The major factors that drive the market for anal cancer therapeutics are aging population, sexually transmitted disease, multiple sexual partners and smoking. According to the World Health Organization 290 million women are suffering from HPV infection and due to unhealthy sex, the chances get doubled. For treating this anal cancer, early diagnosis is crucial which is only available in the developed countries or high-income countries and are accessible. Whereas in the low-income countries the diagnosis and treatment facilities are either costly or inaccessible. These factors are responsible for holding back the anal cancer therapeutics market and should be well tracked for future advancements.
Altogether 80% of anal cancers are developed after the age of 60 and the ones which occur prior to age 35 are mostly observed in men. Almost half of the anal caners are diagnosed before the cancer turns to be malignant but when the cancer is found through early diagnosis are treatable. The survival rate of anal cancer in male is 60% and 70% in female for 5 years. Most of the anal cancers are treated with combination therapy and some are treated with surgery when early diagnosed. Cancer treatment includes chemotherapy, radiation therapy and surgery which is also dependent on the stage of the tumor.
Worldwide there are 1 or 2 cases per 100000 cases and accounts for about 1.5 % of the cases in the United States. Anal cancer therapeutics market share is more in North America followed by Europe. In U.K the incidence cases did not grow in the past few years and thus the anal cancer accounts for less than 1% of all the deaths. In the developed countries and developing countries several epidemiologic studies have found out that the chances for developing anal cancer can be directly related to sexual practices. Also the number of the sexually transmitted diseases has increased over the past couple of years leading to rise in the number of diseases and infections. The developed countries have proper healthcare facilities and thus treatment for anal cancer is possible.
The major market players in the anal cancer therapeutics are GlaxoSmithKline Pharmaceuticals Ltd., Spectrum Pharmaceuticals, Inc., Hospira, Inc., Global BioPharma, Inc., and Advaxis, Inc.

Request Report for Table of Contents @ https://www.persistencemarketresearch.com/toc/10658

Report Highlights:
• Shifting Industry dynamics
• In-depth market segmentation
• Historical, current and projected industry size Recent industry trends
• Key Competition landscape
• Strategies of key players and product offerings
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance

Request to Report Methodology @ https://www.persistencemarketresearch.com/methodology/10658

About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anal Cancer Therapeutics Market to Witness a Pronounce Growth During 2016-2024 here

News-ID: 1059275 • Views: 133

More Releases from Persistence Market Research pvt ltd

Osteoarthritis Treatment Market Analysis By 2025 | Top Key Players are Johnson & …
Persistence Market Research (PMR) has published a new research report on the osteoarthritis treatment market titled “Osteoarthritis Treatment Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025).” An alarming rise in the number of osteoarthritis cases is the result of a growing geriatric population worldwide. In order to cater to the needs of the rapidly increasing geriatric population as well as the female population – given that osteoarthritis prevails mostly among
Soft Tissue Repair Market Opportunity By 2024 | Top Key Players are Baxter, B. B …
Soft tissue repair is a process of replacement of destroyed or injured tissue by healthy tissue. One of the key factors driving the market is the rise in a number of accidents and accidental injuries. This is leading to the soft tissue injuries in ligaments, muscle, and tendons. Soft tissue injuries are being treated with soft tissue fixation devices and scaffolds. Increasing number of sports injuries is also driving the
Biosensor Market Forecast By 2020 | Top Key Players are Abbott Laboratories, Inc …
According to a new market report published by Persistence Market Research “Global Market Study on Biosensor: Asia-Pacific to Witness Highest Growth by 2020,” the global biosensor market was valued at USD 12,963.6 million in 2014 and is expected to grow at a CAGR of 9.7% from 2014 to 2020, to reach an estimated value of USD 22,551.2 million in 2020. To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/3589 Globally, the
Growing Usage in Non-medical Sectors to Create Promising Prospects for Medical & …
Persistence Market Research has estimated the global market for medical & industrial gloves at US$ 12,868.6 Mn by the end of 2026, exhibiting robust expansion at a CAGR of 7.9% over 2018–2026. According to the latest market outlook released by the company, the global Medical & Industrial Gloves Market holds promising growth prospects over the next eight years. The market will benefit from multiple innovations through intense research and

All 5 Releases


More Releases for Anal

Anal Cancer - Pipeline Review, H1 2018
"The Report Anal Cancer - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Anal Cancer Market Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anal Cancer - Pipeline Review, H1 2018, provides an overview of the Anal Cancer (Oncology) pipeline landscape. Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1581042 Anal cancer starts in the anus.
Anal Fissure Treatment Market 2018-2023; By Drug and Surgery
Considering all these factors the market for anal fissure treatment is expected to reach $ 2.6 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 5.2 % during 2017-2023. A anal fissure treatment is a break or tear in the skin of the anal fissure trench described by anal fissure draining and agony amid and after crap. Extending of the anal fissure mucosa
Anal Cancer - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Anal Cancer - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anal Cancer - Pipeline Review, H2 2017, provides an overview of the Anal Cancer (Oncology) pipeline landscape. Anal cancer starts in the anus. Symptoms include rectal bleeding, rectal itching, a lump or mass at the anal
Anal Cancer Therapeutics Development and Professional Review Analysis 2017
Pune, India, 28th August 2017: WiseGuyReports announced addition of new report, titled “Anal Cancer - Pipeline Review, H2 2017”. Summary Anal cancer starts in the anus. Symptoms include rectal bleeding, rectal itching, a lump or mass at the anal opening, pain or a feeling of fullness in the anal area, narrowing of stool, pain or a feeling of fullness in the anal area. Predisposing factors include HPV infections, smoking and lowered immunity. GET
Global Anal Fistula Treatment Market Size, Status and Forecast 2022
This report studies the global Anal Fistula Treatment market, analyzes and researches the Anal Fistula Treatment development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Teva Novartis Pfizer Johnson & Johnson Roche Aptalis Pharma Mylan Aurobindo pharma Bristol Myers Boehringer Ingelheim Get An Exclusive Sample Of The Report : http://www.qyresearchreports.com/sample/sample.php?rep_id=1037537&type=E .... Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Anal Fistula Treatment can
Anal Cancer Pipeline Insight and Therapeutic Assessment Reviewed in 2017
Market Research Hub's latest Pharmaceutical and “Healthcare disease pipeline guide Anal Cancer Pipeline Review”, H2 2017, provides an overview of the Anal Cancer (Oncology) pipeline landscape. Request For Free Sample - http://www.marketresearchhub.com/enquiry.php?type=S&repid=1305531 Anal cancer starts in the anus. Symptoms include rectal bleeding, rectal itching, a lump or mass at the anal opening, pain or a feeling of fullness in the anal area, narrowing of stool, pain or a feeling of fullness